PIK3C3 and cancer: Treatment of cancer cells with autophagy inhibitors (e.g. hydroxochloroquine, Lys05 or Vps34 inhibitors) often ameliorates the efficacy of cancer therapy but in cells with deficient autophagy may promote the survival of these cells [43].